Here we must emphasize that all those approaches would not be effective if the HH-GLI pathway is activated in a non-canonical, ligand-independent manner, e.g., by crosstalk with other signaling pathways [57], and also that in the same subtype of BC both types of pathway activation could be present. This evidence concerns the gene GLI1 and breast cancer.